Aprea Therapeutics, Inc.

US$0.52As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:APREHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR (54.29%)
Div yield —
ROE (60.87%)
Biotechnology
Beta (5Y) 1.69
PE TTM —
TSR TTM (63.03%)
Mkt cap US$6.517M
ROIC (41.09%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.528
1.95%
(83.16%)
Hold 8|9|4|2|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
25.24%
20.93%
21.31%
22.71%
Revenue$M
0.702
0.686
0.677
0.712
12.71%
3.96%
1.60%
5.59%
Peers (US$6.517M)
Cap (US$)
PE
6.509M
—
Capital
TTM
5Y
10Y
Leveragex
1.160
0.058
0.050
EBIT/Intx
0.922
0.609
0.576
Own earn%
(68.22)
18.05
20.21
Sh yield%
38.08
28.33
29.48
Owners
Insiders/Inst%
10.91
84.36
Short interest%
2.25
SBC / revenue%
4.83
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
10–15
$1 testx
—
Incr. ROIC%
13